• Ping Li, Kang Chen, Yi Nie, Ling-Ling Guo, Hai-Bin Wang, Shuang-Shuang Wang, An-Ping Wang, Da-Yi Hu, Yi-Ming Mu, Ji-Hu Li, and DYSIS-China Study Investigators.
• a a Department of Endocrinology , Chinese PLA General Hospital , Beijing , China.
• Curr Med Res Opin. 2015 Jan 1; 31 (9): 1623-31.

ObjectiveTo investigate the associations between obesity and any significant improvements in glycemic control, blood pressure, and lipid targets in Chinese patients with concomitant type 2 diabetes mellitus (T2DM) and hypertension.Methods And ResultsA total of 3041 dyslipidemia patients with an average age of 65.7 ± 10.53 years and comorbid conditions of T2DM and hypertension from the DYSlipidemia International Study (DYSIS) - China were included in the present subgroup analysis. Patients' demographic data, medication use, blood glucose, and lipid parameters were analyzed retrospectively. Body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WtHR) differed significantly among participants according to the attainment of treatment targets. Among female patients, significant differences in the rate of target attainment were observed among different WC, WtHR, and BMI quartile groups, whereas no significant differences in goal attainment were found according to WC and WtHR quartiles in male patients. Among the female patients, the results of logistic regression supported a significant association of anthropometric indices and the achievement of targets.ConclusionA considerable proportion of dyslipidemia patients failed to achieve guideline-recommended targets in China, and this apparent treatment gap was more pronounced among women with central adiposity and patients with an elevated BMI. Based on the limitations of this cross-sectional study, further investigation of the mechanism at the molecular level is necessary.

37 keywords...

hide…